Preliminary Report on the Efficacy and Safety of Triplet Therapy in Patients With Metastatic Hormone‐Sensitive Prostate Cancer: <scp>YUSHIMA</scp> Study
Triplet therapy was highly efficacious and tolerable in Japanese mHSPC patients. Although most patients experienced grade 3-4 neutropenia, no cases were fatal. The deep and early PSA response represents a satisfactory short-term result.
Authors
- Ryoji Takazawa (ORCID: https://orcid.org/0000-0003-1949-1754)
- Yoh Matsuoka (ORCID: https://orcid.org/0000-0002-2440-5104)
- Yosuke Yasuda (ORCID: https://orcid.org/0000-0001-5427-1680)
- Hajime Tanaka (ORCID: https://orcid.org/0000-0003-3632-2901)
- Shunya Matsumoto (ORCID: https://orcid.org/0000-0003-4459-4384)
- Soichiro Yoshida (ORCID: https://orcid.org/0000-0003-2757-8083)
- Yuki Nakamura (ORCID: https://orcid.org/0000-0002-4098-330X)
- Shuichiro Kobayashi
- Junji Yonese (ORCID: https://orcid.org/0000-0001-9266-4020)
- Noboru Numao (ORCID: https://orcid.org/0000-0003-4024-4248)
- Yasuhisa Fujii (ORCID: https://orcid.org/0000-0002-6761-3229)
- Takashi Tamiya
Institutions
- Tokyo Metropolitan Ohtsuka Hospital (JP)
- Saitama Cancer Center (JP)
- Saitama Red Cross Hospital (JP)
- Japanese Foundation For Cancer Research (JP)
- Institute of Science Tokyo (JP)
- National Hospital Organization Saitama Hospital
Publication Details
- Journal
- International Journal of Urology
- Published
- 2025-06-16
- DOI
- https://doi.org/10.1111/iju.70154
- Citations
- 4
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 6.07